Nanobiotix S.A. (EPA:NANO)
France · Delayed Price · Currency is EUR 17.46
-0.50 (-2.78%)
At close: Jan 30, 2026
Nanobiotix Market Cap
Nanobiotix has a market cap or net worth of €844.85 million as of January 30, 2026. Its market cap has increased by 461.15% in one year.
Market Cap
844.85M
Enterprise Value
867.28M
Revenue
10.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
€17.46
Market Cap Chart
Since October 29, 2012, Nanobiotix's market cap has increased from 66.13M to 844.85M, an increase of 1,177.64%. That is a compound annual growth rate of 21.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 844.85M | -10.44% |
| Dec 31, 2025 | 943.39M | 558.09% |
| Dec 31, 2024 | 143.35M | -54.17% |
| Dec 29, 2023 | 312.82M | 147.96% |
| Dec 30, 2022 | 126.16M | -50.42% |
| Dec 31, 2021 | 254.47M | -46.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DBV Technologies | 1.12B |
| Inventiva | 955.16M |
| MedinCell | 746.80M |
| Valneva SE | 674.24M |
| Genfit | 278.85M |
| Transgene | 248.09M |
| Cellectis | 235.06M |
| Innate Pharma | 145.05M |